Back to Search
Start Over
SSTR antagonist [68Ga]Ga-DOTA-LM3 differentiates intrapancreatic accessory spleen from neuroendocrine tumor in a patient presenting indeterminate MRI and SSTR agonist [68Ga]Ga-DOTATATE.
- Source :
- European Journal of Nuclear Medicine & Molecular Imaging; Jan2024, Vol. 51 Issue 2, p606-608, 3p
- Publication Year :
- 2024
-
Abstract
- A 46-year-old woman presented with upper abdominal pain and was initially suspected to have a pancreatic neuroendocrine tumor (NET) based on MRI signs. However, a SSTR2-targeted PET/CT scan using [68Ga]Ga-DOTATATE showed intense radiotracer uptake in the pancreatic nodule, similar to the adjacent spleen. To further differentiate between the two, a [68Ga]Ga-DOTA-LM3 PET/CT scan was performed, which showed no increased uptake in the pancreatic nodule, indicating a lower likelihood of neoplasia. A laparoscopic distal pancreatectomy confirmed the presence of an intrapancreatic accessory spleen (IPAS). This case highlights the challenges in differentiating pancreatic NETs from IPAS and suggests that [68Ga]Ga-DOTA-LM3 PET/CT may be helpful in making this distinction. [Extracted from the article]
- Subjects :
- NEUROENDOCRINE tumors
SPLEEN
MAGNETIC resonance imaging
COMPUTED tomography
Subjects
Details
- Language :
- English
- ISSN :
- 16197070
- Volume :
- 51
- Issue :
- 2
- Database :
- Complementary Index
- Journal :
- European Journal of Nuclear Medicine & Molecular Imaging
- Publication Type :
- Academic Journal
- Accession number :
- 174658091
- Full Text :
- https://doi.org/10.1007/s00259-023-06428-5